Skip to main content
Home > BioCentury on BioBusiness > Analysts

Chronological Index of : Analyst Picks & Changes

 Current Issue
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/5 cls Carbylan Therapeutics Inc. (NASDAQ:CBYL) Leerink Partners Jason Gerberry Downgrade Market perform (from outperform) -75% $0.60…

    Published on 2/8/2016
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/29 cls Invitae Corp. (NYSE:NVTA) Leerink Partners Dan Leonard Downgrade Market perform (from outperform) -13% $7.00 Leonard also …

    Published on 2/1/2016
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/22 cls Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) Piper Jaffray Charles Duncan Upgrade Overweight (from neutral) 3% $24.52 Duncan …

    Published on 1/25/2016
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/15 cls Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) Maxim Group Jason McCarthy Upgrade Hold (from sell) -10% $13.00 McCarthy upgraded…

    Published on 1/18/2016
  • Finance

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/8 cls Charles River Laboratories International Inc. (NYSE:CRL) Wells Fargo Tim Evans Upgrade Outperform (from market perform) -2% $…

    Published on 1/11/2016
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/31 cls ArQule Inc. (NASDAQ:ARQL) RBC Capital Markets Adnan Butt Upgrade Outperform (from sector performer) -3% $2.17 Butt also …

    Published on 1/4/2016
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/18 cls Cerus Corp. (NASDAQ:CERS) Wedbush Zarak Khurshid Downgrade Neutral (from outperform) -8% $5.90 Khurshid downgraded, noting …

    Published on 12/21/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/11 cls Agios Pharmaceuticals Inc. (NASDAQ:AGIO) Leerink Partners Seamus Fernandez Downgrade Market perform 
(from outperform) -13%…

    Published on 12/14/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/4 cls Cepheid Inc. (NASDAQ:CPHD) Wells Fargo Tim Evans Downgrade Market perform (from outperform) -10% $33.43 Evans also lowered …

    Published on 12/7/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/20 cls Clovis Oncology Inc. (NASDAQ:CLVS) Mizuho Eric Criscuolo Downgrade Neutral (from buy) -73% $26.41 Criscuolo also lowered …

    Published on 11/23/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/13 cls Insmed Inc. (NASDAQ:INSM) UBS Matthew Roden Downgrade Neutral (from buy) -6% $16.05 Roden also lowered his target to $18 …

    Published on 11/16/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/6 cls Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) Piper Jaffray Charles Duncan Downgrade Neutral (from overweight) 6% $36.75 Duncan …

    Published on 11/9/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/23 cls Biogen Inc. (NASDAQ:BIIB) Baird Brian Skorney Price target Neutral 2% $276.99 H.C. Wainwright Andrew Fein Price target …

    Published on 10/26/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/16 cls Charles River Laboratories International Inc. (NYSE:CRL) Wells Fargo Tim Evans Upgrade Market perform (from underperform) 2%…

    Published on 10/19/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/9 cls Amicus Therapeutics Inc. (NASDAQ:FOLD) Chardan Capital Gbola Amusa Upgrade Buy (from neutral) 19% $7.58 Amusa upgraded on …

    Published on 10/12/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/2 cls Celgene Corp. (NASDAQ:CELG) JPMorgan Cory Kasimov Upgrade Overweight (from neutral) 7% $116.44 Kasimov upgraded on valuation…

    Published on 10/5/2015
  • Finance

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/25 cls Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) H.C. Wainwright Ed Arce New Buy 11% $5.16 Arce initiated coverage with a $15 …

    Published on 9/28/2015
  • Finance

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/18 cls Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) Barclays Capital Geoffrey Meacham Downgrade Equal weight (from overweight) -3% $…

    Published on 9/21/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/11 cls Amgen Inc. (NASDAQ:AMGN) UBS Matthew Roden Upgrade Buy (from neutral) 4% $153.21 Roden also raised his target to $168 from $…

    Published on 9/14/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/4 cls Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) Piper Jaffray Charles Duncan Upgrade Overweight (from neutral) 3% $39.46 Duncan …

    Published on 9/7/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/21 cls Avalanche Biotechnologies Inc. (NASDAQ:AAVL) Chardan Capital Gbola Amusa Upgrade Buy (from neutral) 6% $10.62 Amusa upgraded…

    Published on 8/24/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/14 cls Intrexon Corp. (NYSE:XON) JPMorgan Tycho Peterson Downgrade Neutral (from overweight) -20% $47.52 Mizuho Peter Lawson …

    Published on 8/17/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/7 cls Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) Piper Jaffray Charles Duncan Downgrade Neutral (from overweight) -20% $39.14 Duncan…

    Published on 8/10/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/31 cls Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) Jefferies Eun Yang Upgrade Buy (from hold) 9% $19.13 Yang upgraded, saying the …

    Published on 8/3/2015
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/24 cls Biogen Inc. (NASDAQ:BIIB) BMO Capital Markets Jim Birchenough Downgrade Market perform (from outperform) -26% $300.03 …

    Published on 7/27/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993